Literature DB >> 16622275

New issues on cetuximab mechanism of action in epidermal growth factor receptor-negative colorectal cancer: the role of vascular endothelial growth factor.

Bruno Vincenzi, Daniele Santini, Giuseppe Tonini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622275     DOI: 10.1200/JCO.2005.05.0450

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Role of cetuximab in first-line treatment of metastatic colorectal cancer.

Authors:  Miguel Jhonatan Sotelo; Beatriz García-Paredes; Carlos Aguado; Javier Sastre; Eduardo Díaz-Rubio
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  A case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastases.

Authors:  Eric Marks; Syed Mujtaba Rizvi; Nabeel Sarwani; Zhaohai Yang; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 3.  Sensitivity and resistance to EGF-R inhibitors: approaches to enhance the efficacy of EGF-R antibodies.

Authors:  Matthias Peipp; Michael Dechant; Thomas Valerius
Journal:  MAbs       Date:  2009-11-11       Impact factor: 5.857

4.  Evaluation and comparison of human absorbed dose of (90)Y-DOTA-Cetuximab in various age groups based on distribution data in rats.

Authors:  Ariandokht Vakili; Amir Reza Jalilian; Alireza Khorrami Moghadam; Maryam Ghazi-Zahedi; Bahram Salimi
Journal:  J Med Phys       Date:  2012-10

5.  Targeted Magnetic Nanoparticles for Mechanical Lysis of Tumor Cells by Low-Amplitude Alternating Magnetic Field.

Authors:  Adi Vegerhof; Eran A Barnoy; Menachem Motiei; Dror Malka; Yossef Danan; Zeev Zalevsky; Rachela Popovtzer
Journal:  Materials (Basel)       Date:  2016-11-22       Impact factor: 3.623

Review 6.  Combination Radioimmunotherapy Strategies for Solid Tumors.

Authors:  Javeria Zaheer; Hyeongi Kim; Yong-Jin Lee; Jin Su Kim; Sang Moo Lim
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.